Cancer Trials Ireland Company Limited By Guarantee

Cancer Trials Ireland Company Limited By Guarantee is an organisation in Dublin 2, Ireland that has taken part in 5 EU-funded projects since 2012, receiving €736k in EU funding.

EU funding received€736k
EU projects5
As coordinator0
Running now2
First EU project2012
Latest project2025
CountryIreland
EU registration (PIC)962406453
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Cancer Trials Ireland Company Limited By Guarantee's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€277k · 1 project
  • Horizon Europe€258k · 2 projects
  • Horizon 2020€201k · 2 projects

Projects

5 EU-funded projects, newest first. Each links to the official record.

  • PATH-FOR-YOUNGPartner

    Personalized Adjuvant Treatment for HR+/HER2- breast cancer FOR YOUNG patients

    Horizon Europe · 2025–2031 · Project on CORDIS ↗

    €158ktheir share
  • DE-ESCALATEPartner

    INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €100ktheir share
  • COLOSSUSPartner

    Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €201ktheir share
  • GLIOTRAINPartner

    Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • ANGIOPREDICTPartner

    Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €277ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • colorectal cancer
  • drug discovery
  • immunotherapy
  • machine learning
  • mutation
  • oncology
  • personalized medicine
  • public health

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime